本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Acumen Pharmaceuticals, Inc.

2.57
+0.01000.39%
盤後2.570.0002+0.01%18:36 EDT
成交量:43.06萬
成交額:113.67萬
市值:1.86億
市盈率:-1.28
高:2.74
開:2.54
低:2.54
收:2.56
52周最高:3.60
52周最低:0.9706
股本:7,221.28萬
流通股本:4,091.36萬
量比:1.61
換手率:1.05%
股息:- -
股息率:- -
每股收益(TTM):-2.0035
每股收益(LYR):-2.0035
淨資產收益率:-96.20%
總資產收益率:-42.78%
市淨率:2.64
市盈率(LYR):-1.28

資料載入中...

2026/04/08

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/31

SEC問詢函

Form CORRESP - Correspondence
2026/03/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/26

重要事件披露

Form 8-K - Current report
2026/03/16

重要事件披露

Form 8-K - Current report
2026/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities